Extended spectrum β lactamase-producing Klebsiella pneumoniae infections: A review of the literature

[1] Itokazu G., Quinn J., Bell-Dixon C., Kahan F., Weinstein R., Antimicrobial resistance rates among aerobic Gram-negative bacilli recovered from patients ini intensive care units: Evaluation of a national postmarketing surveillance program, Clin. Infect. Dis., 23, pp. 779-784, (1996)

[2] Burwen D.R., Banerjee S.N., Gaynes R.P., Cerftazidime resistance among selected nosocomial Gram-negative bacilli in the United States, J. Infect. Dis., 170, pp. 1622-1625, (1994)

[3] Karas J.A., Pillay D.G., Muckart D., Sturm A.W., Treatment failure due to extended spectrum β-lactamase, J. Antimicrob. Chemother., 37, pp. 203-204, (1996)

[4] Podschun R., Ullman U., Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors, Clin. Microbiol. Rev., 11, pp. 589-603, (1998)

[5] Morgan M.E., Hart C.A., Cooke R.W., Klebsiella infection in a neonatal intensive care unit: Role of bacteriological surveillance, J. Hosp. Infect., 5, pp. 377-385, (1984)

[6] Knothe H., Shah P., Krcmery V., Antal M., Mitsuhashi S., Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens, Infection, 11, pp. 315-317, (1983)

[7] Quinn J.P., Miyashiro D., Sahm D., Flamm R., Bush K., Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae, Antimicrob. Agents Chemother., 33, pp. 1451-1456, (1989)

[8] Quale J.M., Landman D., Bradford P.A., Et al., Molecular epidemiology of a citywide outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection, Clin. Infect. Dis., 35, pp. 834-841, (2002)

[9] Athamma A., Ofek I., Keisari Y., Et al., Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages, Infect. Immun., 59, pp. 1673-1682, (1991)

[10] Griffiths E., Chart H., Stevenson P., High affinity iron uptake systems and bacterial virulence, Virulence Mechanics of Bacterial Pathogens, pp. 121-137, (1988)

[1] Itokazu G., Quinn J., Bell-Dixon C., Kahan F., Weinstein R., Antimicrobial resistance rates among aerobic Gram-negative bacilli recovered from patients ini intensive care units: Evaluation of a national postmarketing surveillance program, Clin. Infect. Dis., 23, pp. 779-784, (1996)

[2] Burwen D.R., Banerjee S.N., Gaynes R.P., Cerftazidime resistance among selected nosocomial Gram-negative bacilli in the United States, J. Infect. Dis., 170, pp. 1622-1625, (1994)

[3] Karas J.A., Pillay D.G., Muckart D., Sturm A.W., Treatment failure due to extended spectrum β-lactamase, J. Antimicrob. Chemother., 37, pp. 203-204, (1996)

[4] Podschun R., Ullman U., Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors, Clin. Microbiol. Rev., 11, pp. 589-603, (1998)

[5] Morgan M.E., Hart C.A., Cooke R.W., Klebsiella infection in a neonatal intensive care unit: Role of bacteriological surveillance, J. Hosp. Infect., 5, pp. 377-385, (1984)

[6] Knothe H., Shah P., Krcmery V., Antal M., Mitsuhashi S., Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens, Infection, 11, pp. 315-317, (1983)

[7] Quinn J.P., Miyashiro D., Sahm D., Flamm R., Bush K., Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae, Antimicrob. Agents Chemother., 33, pp. 1451-1456, (1989)

[8] Quale J.M., Landman D., Bradford P.A., Et al., Molecular epidemiology of a citywide outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection, Clin. Infect. Dis., 35, pp. 834-841, (2002)

[9] Athamma A., Ofek I., Keisari Y., Et al., Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages, Infect. Immun., 59, pp. 1673-1682, (1991)

[10] Griffiths E., Chart H., Stevenson P., High affinity iron uptake systems and bacterial virulence, Virulence Mechanics of Bacterial Pathogens, pp. 121-137, (1988)